Observe Medical announces early launch of UnoMeter[TM] Safeti Plus
Oslo, 27 May 2024 – Observe Medical ASA ("the Company" or "Observe Medical") is pleased to announce the early launch of the UnoMeterTM Safeti Plus, a market-leading Hourly Diuresis Monitoring System with a proven track record of safety and effectiveness.
This early launch is a direct result of the strong collaboration between Observe Medical's product development team and our external manufacturing partner. The UnoMeter™ Safeti Plus has enjoyed decades of success under Convatec, accounting for the majority of the company’s historical sales in this segment.
The UnoMeter™ Safeti Plus joins the existing UnoMeter™ 500 and UnoMeter™ Abdo-Pressure™ products, creating a comprehensive UnoMeter™ portfolio. This portfolio positions Observe Medical for significant revenue growth and continued geographical expansion.
The UnoMeter™ Safeti Plus launch marks a major milestone in Observe Medical's strategic journey. It also lays the groundwork for the upcoming launch of UnoMeter™ Sippi, the next generation of hourly diuresis monitoring solutions.
For further information, please contact:
Jørgen Mann, Interim CEO Observe Medical
Mobile: +45 408 67 558
E-mail: [email protected]
Rune Nystad, CDO Observe Medical
Mobile: +47 916 24 683
E-mail: [email protected]
About Observe Medical
Observe Medical is a Nordic medtech company that develops, markets and sells innovative medtech products for the global market. The Company is committed to improving patient welfare and patient outcomes, improving clinical data accuracy and promoting positive health economics.
The Company seeks to drive growth by leveraging its expertise in sales and commercialization of its broad portfolio of medical technology products, mainly in urine measurement and ultrasound, in combination with targeted M&A and distribution. Observe Medical is working with a network of leading distributors to provide outstanding solutions for healthcare professionals globally.
The Company is headquartered in Oslo, Norway.
Further information is available at www.observemedical.com.